• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Becton Dickinson and Co (BDX)

Common Stock
Sell: $170.43|Buy: $179.90|Change: 1.92 (-1.08%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents,as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.

Address

1 Becton Drive
Franklin Lakes
NJ
USA
07417-1880

Telephone

+1 800 2846845

Website

https://www.bd.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Becton Dickinson & Co First Quarter Earnings Conference Call for 20272027-02-09T08:00:00
Becton Dickinson & Co First Quarter Earnings Results for 20272027-02-09T00:00:00
Becton Dickinson & Co Annual General Meeting for 20272027-01-27T13:00:00
Becton Dickinson & Co Annual Report for 20262026-11-25T00:00:00
Becton Dickinson & Co Fourth Quarter Earnings Conference Call for 20262026-11-06T08:00:00
Becton Dickinson & Co Fourth Quarter Earnings Results for 20262026-11-06T00:00:00
Becton Dickinson & Co Third Quarter Earnings Conference Call for 20262026-08-07T08:00:00
Becton Dickinson & Co Third Quarter Earnings Results for 20262026-08-07T00:00:00
Becton Dickinson & Co Second Quarter Earnings Conference Call for 20262026-05-01T08:00:00
Becton Dickinson & Co Second Quarter Earnings Results for 20262026-05-01T00:00:00
Becton Dickinson & Co First Quarter Earnings Conference Call for 20262026-02-09T08:00:00
Becton Dickinson & Co First Quarter Earnings Results for 20262026-02-09T00:00:00

Previous key dates

NameKey Date
Becton Dickinson & Co First Quarter Earnings Conference Call for 20262026-02-09T08:00:00
Becton Dickinson & Co First Quarter Earnings Results for 20262026-02-09T00:00:00
Becton Dickinson & Co Annual General Meeting for 20262026-01-27T13:00:00
Becton Dickinson & Co Annual Report for 20252025-11-25T00:00:00
Becton Dickinson & Co Fourth Quarter Earnings Conference Call for 20252025-11-06T08:00:00
Becton Dickinson & Co Fourth Quarter Earnings Result for 20252025-11-06T00:00:00
BD to Present at Wells Fargo Healthcare Conference 20252025-09-03T08:00:00
Becton Dickinson & Co Third Quarter Earnings Conference Call for 20252025-08-07T08:00:00
Becton Dickinson & Co Third Quarter Earnings Result for 20252025-08-07T00:00:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-09T14:00:00
Bank of America Securities Health Care Conference2025-05-13T13:00:00
Becton Dickinson & Co Second Quarter Earnings Conference Call for 20252025-05-01T08:00:00
Becton Dickinson & Co Second Quarter Earnings Results for 20252025-05-01T00:00:00
Barclays 27th Annual Global Healthcare Conference2025-03-11T08:30:00
Citi's 2025 Unplugged Medtech and Life Sciences Access Day2025-02-27T08:45:00
Becton Dickinson & Co First Quarter Earnings Conference Call for 20252025-02-06T08:00:00
Becton Dickinson & Co First Quarter Earnings Result for 20252025-02-06T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.